The Pharmacy Times® Pain Management resource center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, among other items that pharmacists will find valuable.
What can we help you find?
In a recent study analyzing US commercial dental visits between 2011 and 2015, 29.3% of dental visits included opioid prescriptions that exceeded the recommended amount of less than 80 morphine milligram equivalents.
Cannabis use is becoming much more prevalent in the United States, as several more states have recently legalized it for recreational or medicinal use.
Statin use in certain patients may lead to increased muscle pain so severe it can affect adherence.
Approximately 1 in 3 high school seniors (31.8%) who reported misusing prescription opioids as high school seniors between 1997 and 2000 went on to use heroin by age 35.
This month's featured products include magnesium chews, pre and probiotic fiber, and more.
When 3 citizens of a Southern state file suit against government officials to have a state statute classifying marijuana as an illegal substance declared unconstitutional, should the courts make such a declaration and issue an injunction prohibiting enforcement of the laws?
This month's case studies feature lower back pain, hand osteoarthritis, and more.
APhA Academy of Student Pharmacists Partners with Walmart for Operation Substance Use Disorders Project
The new project follows a collaboration with Walmart announced in August, offering a free comprehensive online training program on opioid stewardship.
Given the evidence of emotional trauma, hopelessness, and social isolation as risk factors for addiction, compassion and support are critical.
The study found that of 568 patients surveyed, 15% had used cannabis within the past 3 years, with half of the users reporting using it regularly and mostly for medical purposes.
Although earlier research has shown slight reductions in opioid abuse rates, this analysis is the first to show statistically significant year-to-year declines.
This webcast discusses a number of topics pertaining to the substance use epidemic and updates in the use of naloxone especially during the COVID-19 pandemic.